Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Progress in radiation maculopathy fight
BioMed X and Novo Nordisk collaborating on oral peptide drug delivery
Phase II study in non-muscle invasive bladder cancer completed
Solid tumour clinical trial completed
BeginNGS to screen newborns for more than 1,000 treatable genetic disorders
Singzyme bioconjugation platform wins Golden Ticket Programme
“New dawn for respiratory medicine”
Robotics transforming cell therapy with 74% cost reduction